Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats

Microvascular Research

Volumn 87, Issue , 2013, Pages 65-74

  Kumar, Binit ^a   Gupta, Suresh Kumar ^a   Srinivasan, B P ^a   Nag, Tapas Chandra ^b   Srivastava, Sushma ^a   Saxena, Rohit ^c   Jha, Kumar Abhiram ^b  

^a UNIVERSITY OF DELHI   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; CASPASE 3; CATALASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HESPERETIN; INTERLEUKIN 1BETA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG STRUCTURE; FEMALE; HYPERGLYCEMIA; MALE; MUELLER CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR; PRIORITY JOURNAL; RAT; RETINA DEGENERATION; RETINA GANGLION CELL; STREPTOZOCIN DIABETES;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; AQUAPORIN 4; BLOOD GLUCOSE; BODY WEIGHT; CASPASE 3; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HESPERIDIN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINA; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84876345768     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.01.002     Document Type: Article

References (55)

1. Allen D.A., Yaqoob M.M., Harwood S.M. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J. Nutr. Biochem. 2005, 12:705-713.
2. Aranganathan S., Nalini N. Efficacy of the potential chemopreventive agent, hesperetin (citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis. Food Chem. Toxicol. 2009, 47:2594-2600.
3. Aranganathan S., Selvam J.P., Sangeetha N., Nalini N. Modulatory efficacy of hesperetin (citrus flavanone) on xenobiotic-metabolizing enzymes during 1,2-dimethylhydrazine-induced colon carcinogenesis. Chem. Biol. Interact. 2009, 180:254-261.
4. Armstrong D., Santangelo G., Connole E. The distribution of peroxide regulating enzyme in canine eye. Curr. Eye Res. 1981, 1:225-242.
5. Bamforth S.D., Lightman S.L., Greenwood J. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine. Am. J. Pathol. 1997, 50:329-340.
6. Behl Y., Krothapalli P., Desta T., DiPiazza A., Roy S., Graves D.T. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am. J. Pathol. 2008, 172:1411-1418.
7. Bringmann A., Francke M., Reichenbach A. Müller cells in retinopathies. Adv. Mol. Cell Biol. 2004, 31:1117-1132.
8. Bringmann A., Uckermann O., Pannicke T., Iandiev I., Reichenbach A., Wiedemann P. Neuronal versus glial cell swelling in the ischaemic retina. Acta Ophthalmol. Scand. 2005, 83:528-538.
9. Casaroli Marano R.P., Preissner K.T., Vilaro S. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp. Eye Res. 1995, 60:5-17.
10. Castorina C., Campisi A., Di Giacomo C. Lipid peroxidation and antioxidant enzymatic systems in rat retina as a function of age. Neurochem. Res. 1992, 17:599-604.
11. Choi E.J. Antioxidative effects of hesperetin against 7, 12-dimethylbenz (a)anthracene-induced oxidative stress in mice. Life Sci. 2008, 82:1059-1064.
12. Choi E.J., Ahn W.S. Neuroprotective effects of chronic hesperetin administration in mice. Arch. Pharm. Res. 2008, 31:1457-1462.
13. Da T., Verkman A.S. Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest. Ophthalmol. Vis. Sci. 2004, 45:4477-4483.
14. Doonan F., Cotter T.G. Apoptosis: a potential therapeutic target for retinal degenerations. Curr. Neurovasc. Res. 2004, 1:41-53.
15. Dubois-Dauphin M., Poitry-Yamate C., de Bilbao F., Julliard A.K., Jourdan F., Donati G. Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice. Neuroscience 2000, 95:9-21.
16. Feit-Leichman R.A., Kinouchi R., Takeda M., Fan Z., Mohr S., Kern T.S., Chen D.F. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest. Ophthalmol. Vis. Sci. 2005, 46:4281-4287.
17. Foss M.C., Foss N.T., Paccola G.M., Silva C.L. Serum levels of tumor necrosis factor in insulin-dependent diabetic patients. Braz. J. Med. Biol. Res. 1992, 25:239-242.
18. Gupta S.K., Kumar B., Nag T.C., Agrawal S.S., Agrawal R., Agrawal P., Saxena R., Srivastava S. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocul. Pharmacol. Ther. 2011, 27:123-130.
19. Gupta S.K., Kumar B., Srinivasan B.P., Nag T.C., Srivastava S., Saxena R. Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. J. Ocul. Pharmacol. Ther. 2012, 10.1089/jop. 2012.0089.
20. Gürler B., Vural H., Yilmaz N., Oguz H., Satici A., Aksoy N. The role of oxidative stress in diabetic retinopathy. Eye 2000, 5:730-735.
21. Hirata A., Murakami Y., Shoji M., Kadoma Y., Fujisawa S. Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer Res. 2005, 25:3367-3374.
22. 2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem. 2008, 56:859-864.
23. Joussen A.M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A.P. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002, 16:438-440.
24. Joussen A.M., Poulaki V., Mitsiades N., Cai W.Y., Suzuma I., Pak J., Ju S.T., Rook S.L., Esser P., Mitsiades C.S., Kirchhof B., Adamis A.P., Aiello L.P. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003, 17:76-78.
25. Katai N., Yoshimura N. Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest. Ophthalmol. Vis. Sci. 1999, 40:2697-2705.
26. Kern T.S., Tang J., Mizutani M., Kowluru R.A., Nagaraj R.H., Romeo G., Podesta F., Lorenzi M. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest. Ophthalmol. Vis. Sci. 2000, 12:3972-3978.
27. Kim J.Y., Jung K.J., Choi J.S., Chung H.Y. Hesperetin: a potent antioxidant against peroxynitrite. Free Radic. Res. 2004, 38:761-769.
28. Kowluru R.A., Koppolu P. Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities. Invest. Ophthalmol. Vis. Sci. 2002, 43:3287-3291.
29. Kowluru R.A., Koppolu P. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic. Res. 2002, 36:993-999.
30. Kowluru V., Kowluru R.A. Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina. Mol. Vis. 2007, 13:602-610.
31. Kowluru R.A., Odenbach S. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest. Ophthalmol. Vis. Sci. 2004, 45:4161-4166.
32. Kowluru R.A., Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br. J. Ophthalmol. 2004, 88:1343-1347.
33. Kowluru R.A., Tang J., Kern T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001, 50:1938-1942.
34. Kowluru R.A., Koppolu P., Chakrabarti S., Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic. Res. 2003, 37:1169-1180.
35. Kumar B., Gupta S.K., Nag T.C., Srivastava S., Saxena R. Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Ophthalmic Res. 2012, 47:103-108.
36. Kumar B., Gupta S.K., Srinivasan B.P., Nag T.C., Srivastava S., Saxena R. Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats. Vascul. Pharmacol. 2012, 57:201-207.
37. Liu X.Q., Kobayashi H., Jin Z.B., Wada A., Nao-i N. Differential expression of Kir4. 1 and aquaporin 4 in the retina from endotoxin-induced uveitis rat. Mol. Vis. 2007, 13:309.
38. Masuzawa K., Goto K., Jesmin S., Maeda S., Miyauchi T., Kaji Y., Oshika T., Hori S. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Curr. Eye Res. 2006, 31:79-89.
39. Mizutani M., Gerhardinger C., Lorenzi M. Müller cell changes in human diabetic retinopathy. Diabetes 1998, 47:445-449.
40. Morin B., Nichols L.A., Zalasky K.M., Davis J.W., Manthey J.A., Holland L.J. The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells. J. Nutr. 2008, 138:1274-1281.
41. Nagelhus E.A., Veruki M.L., Torp R., Haug F.M., Laake J.H., Nielsen S., Ottersen O.P. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J. Neurosci. 1998, 18:2506-2519.
42. Nagelhus E.A., Mathiisen T.M., Ottersen O.P. Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4. 1. Neuroscience 2004, 129:905-913.
43. Obrosova I.G., Drel V.R., Kumagai A.K., Szábo C., Pacher P., Stevens M.J. Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia 2006, 49:2525-2533.
44. Pollard S.E., Whiteman M., Spencer J.P. Modulation of peroxynitrite induced fibroblast injury by hesperetin: a role for intracellular scavenging and modulation of ERK signalling. Biochem. Biophys. Res. Commun. 2006, 347:916-923.
45. Romeo G., Liu W.H., Asnaghi V., Kern T.S., Lorenzi M. Activation of nuclear factor-kB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002, 51:2241-2248.
46. Roy S., Sato T., Paryani G., Kao R. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 2003, 52:1229-1234.
47. Sharma V., Mishra M., Ghosh S., Tewari R., Basu A., Seth P., Sen E. Modulation of interleukin-1β mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res. Bull. 2007, 73:55-63.
48. Siperstein M.D., Norton W., Unger R.H., Madison L.L. Muscle capillary basement membrane width in normal, diabetic and prediabetic patients. Trans. Assoc. Am. Physicians 1966, 79:330-347.
49. Spirin K.S., Saghizadeh M., Lewin S.L., Zardi L., Kenney M.C., Ljubimov A.V. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr. Eye Res. 1999, 18:490-499.
50. Vafeiadou K., Vauzour D., Lee H.Y., Rodriguez-Mateos A., Williams R.J., Spencer J.P. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch. Biochem. Biophys. 2009, 484:100-109.
51. Xagorari A., Papapetropoulos A., Mauromatis A., Economou M., Fotsis T., Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J. Pharmacol. Exp. Ther. 2001, 296:181-187.
52. Yang L.P., Sun H.L., Wu L.M., Guo X.J., Dou H.L., Tso M.O., Zhao L., Li S.M. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2009, 50:2319-2327.
53. Zernecke A., Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc. Res. 2010, 86:192-201.
54. Zhang W., Liu H., Al-Shabrawey M., Caldwell R.W., Caldwell R.B. Inflammation and diabetic retinal microvascular complications. J. Cardiovasc. Dis. Res. 2011, 2:96-103.
55. Zorena K., Myśliwska J., Myśliwiec M., Balcerska A., Hak Ł., Lipowski P., Raczyńska K. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Mediators Inflamm. 2007, 2007:92196.